ArticleDigestive diseases and sciences2026

Risk of Incident Immune-Mediated Inflammatory Diseases with Second Tumor Necrosis Factor Inhibitor Versus Alternative Biologic Therapy in Patients with Inflammatory Bowel Disease and First TNFi Exposure: A Real-World Cohort Study.

Aakash Desai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.